Independent provider comparison
Updated September 21, 2026
MangoRx vs MEDVi: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
The decision
Which should you choose, MangoRx or MEDVi?
Short answer: MangoRx scores higher on our published rubric, 7.5/10 against 5.7/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; MEDVi is $179 first month, then $299/mo.
Consider MangoRx if
Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company.
Consider MEDVi if
Users who want both oral and injectable compounded options in one telehealth program.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
MangoRx
#12 of 36Best for needle-phobic users who want oral-only glp-1 tablets from a publicly traded company.
Visit MangoRx
MEDVi
#25 of 36Best for users who want both oral and injectable compounded options in one telehealth program.
Visit MEDViSide by side
MangoRx vs MEDVi at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | MangoRx | MEDVi |
|---|---|---|
| Why each one | Oral dissolving tablets exclusively (zero injections) from a publicly traded company (NASDAQ: MGRX) with SEC-level financial transparency. | A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. |
| Our Score | 7.5/10 | 5.7/10 |
| Headline Price | from $299/mo | $179 first month, then $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you. | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #12 | #25 |
| Get started | Visit MangoRx | Visit MEDVi |
Trade-offs
Strengths and cautions compared
MangoRx
Pros
- +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
1 more documented strengths
- +Intake is 100% online with no insurance needed, and the provider visit costs nothing when it ends in a prescription
Cons
- −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
- −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
- −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MangoRx edges out MEDVi with a score of 7.5/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Cost decisionCompare complete recurring program costsSee which prices include medication, clinical care and shipping, and which headline amounts require another fee or commitment.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both MangoRx and MEDVi start above the cheapest complete recurring program we track. Across all 36 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving MangoRx and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare MangoRx and Willowfrom $299/mo
- Compare MangoRx and Direct Meds GLP-1from $297/mo
- Compare MangoRx and Enhance MDfrom $212/mo
- Compare MEDVi and HealthRXfrom $99/mo
- Compare MEDVi and Collectivefrom $59/mo + $199/year membership after 21 days
- Compare MEDVi and Shedfrom $159/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is MEDVi legit, with the verification evidence behind each answer.
Our pick of these two: MangoRx · 7.5/10